Hu Y - Search Results

1

Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis.

Hu Y, Coates AR, Mitchison DA. Hu Y, et al. Antimicrob Agents Chemother. 2003 Feb;47(2):653-7. doi: 10.1128/AAC.47.2.653-657.2003. Antimicrob Agents Chemother. 2003. PMID: 12543673 Free PMC article.

2

Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies.

Hu Y, Coates AR. Hu Y, et al. J Antimicrob Chemother. 2013 Feb;68(2):374-84. doi: 10.1093/jac/dks384. Epub 2012 Oct 4. J Antimicrob Chemother. 2013. PMID: 23042813

3

Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.

Soren O, Brinch KS, Patel D, Liu Y, Liu A, Coates A, Hu Y. Soren O, et al. Among authors: hu y. Antimicrob Agents Chemother. 2015 Oct;59(10):6233-40. doi: 10.1128/AAC.01245-15. Epub 2015 Jul 27. Antimicrob Agents Chemother. 2015. PMID: 26248380 Free PMC article.

4

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro.

Clewe O, Aulin L, Hu Y, Coates AR, Simonsson US. Clewe O, et al. Among authors: hu y. J Antimicrob Chemother. 2016 Apr;71(4):964-74. doi: 10.1093/jac/dkv416. Epub 2015 Dec 24. J Antimicrob Chemother. 2016. PMID: 26702921 Free PMC article.

5

Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.

Hu Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, Liu Y, Schipani A, Davies G, Coates A. Hu Y, et al. Antimicrob Agents Chemother. 2016 Jul 22;60(8):4778-85. doi: 10.1128/AAC.02548-15. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27216065 Free PMC article.

6

Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.

Liu Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, Harrison T, Davies G, Coates A, Hu Y. Liu Y, et al. Among authors: hu y. J Antimicrob Chemother. 2018 Mar 1;73(3):724-731. doi: 10.1093/jac/dkx467. J Antimicrob Chemother. 2018. PMID: 29244108

7

A Method to Evaluate Persistent Mycobacterium tuberculosis In Vitro and in the Cornell Mouse Model of Tuberculosis.

Hu Y, Coates A. Hu Y, et al. Methods Mol Biol. 2018;1736:157-166. doi: 10.1007/978-1-4939-7638-6_15. Methods Mol Biol. 2018. PMID: 29322468

8

Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.

Liu Y, Pertinez H, Davies GR, Gillespie SH, Coates AR, Hu Y. Liu Y, et al. Among authors: hu y. Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00190-18. doi: 10.1128/AAC.00190-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29661869 Free PMC article.

9

Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant Enterobacteriaceae.

Hu Y, Liu Y, Coates A. Hu Y, et al. Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01630-18. doi: 10.1128/AAC.01630-18. Print 2019 Jan. Antimicrob Agents Chemother. 2018. PMID: 30373798 Free PMC article.

10

Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.

Hu Y, Pertinez H, Liu Y, Davies G, Coates A. Hu Y, et al. J Antimicrob Chemother. 2019 Jun 1;74(6):1627-1633. doi: 10.1093/jac/dkz052. J Antimicrob Chemother. 2019. PMID: 30789209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,660 results

Search Page

Filters